Epigenetic modifications in fibrotic diseases: Implications for pathogenesis and pharmacological targets

Journal of Pharmacology and Experimental Therapeutics

Volumn 352, Issue 1, 2015, Pages 2-13

  Yao, Hong Wei ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE; HISTONE H3; METHYL CPG BINDING PROTEIN 2; MICRORNA; MICRORNA 152; MICRORNA 155; MICRORNA 19B; MICRORNA 21; MICRORNA 29; UNCLASSIFIED DRUG; UNTRANSLATED RNA; HISTONE;

ARTICLE; DNA METHYLATION; DNA MODIFICATION; DNA TRANSCRIPTION; DNMT1 GENE; DRUG TARGETING; EPIGENETICS; FIBROSIS; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; LIVER FIBROSIS; MOLECULAR PATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PROCESSING; RASAL1 GENE; ANIMAL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; FIBROSIS; HISTONES; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY;

EID: 84919733534     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.219816     Document Type: Article

References (203)

1. Affo S and Sancho-Bru P (2014) CCL2: a link between hepatic inflammation, fibrosis and angiogenesis? Gut DOI: 10.1136/gutjnl-2014-306905 [published ahead of print]
2. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, and Zwerina J, et al. (2012) Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun 3:735.
3. 2+ overload and cell death. J Clin Invest 122:1222-1232.
4. Azrak SS, Ginel-Picardo A, Drosten M, Barbacid M, and Santos E (2013) Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: functional and mechanistic implications. BMC Genomics 14:731.
5. Bannister AJ and Kouzarides T (2005) Reversing histone methylation. Nature 436:1103-1106.
6. Bao H, Hu S, Zhang C, Shi S, Qin W, Zeng C, Zen K, and Liu Z (2014) Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy. Biochem Biophys Res Commun 444:455-460.
7. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A, Näslund E, and Zierath JR (2013) Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Reports 3:1020-1027.
8. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, and Zierath JR (2009) Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10:189-198.
9. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
10. Baylin SB and Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168-174.
11. Bechtel W, McGoohan S, Zeisberg EM, Müller GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R, and Zeisberg M (2010) Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16:544-550.
12. Bestor TH (2000) The DNA methyltransferases of mammals. Hum Mol Genet 9:2395-2402.
13. Bian EB, Huang C, Ma TT, Tao H, Zhang H, Cheng C, Lv XW, and Li J (2012) DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol 264:13-22.
14. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, Vinciguerra M, Rosenthal N, Sciacca S, and Pilato M, et al. (2011) MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 109:1115-1119.
15. Bowen T, Jenkins RH, and Fraser DJ (2013) MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol 229:274-285.
16. Calvisi DF, Ladu S, Conner EA, Seo D, Hsieh JT, Factor VM, and Thorgeirsson SS (2011) Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol 54:311-319.
17. Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, Li J, Tran PT, Kaimal V, and Huang X, et al. (2012) MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 4:121ra118.
18. Chen C, Wu CQ, Zhang ZQ, Yao DK, and Zhu L (2011) Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 317:1714-1725.
19. Chen CC, Wang KY, and Shen CK (2012) The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J Biol Chem 287:33116-33121.
20. Cheng X, Gao W, Dang Y, Liu X, Li Y, Peng X, and Ye X (2013) Both ERK/MAPK and TGF-Beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation. J Diabetes Res 2013:463740.
21. Cheung P and Lau P (2005) Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol 19:563-573.
22. Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, Gelatti U, Bucella E, Tomasi E, and Portolani N, et al. (2000) Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev 9:213-216.
23. Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, and Zhang S, et al. (2011) Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Med Genomics 4:8.
24. Cisneros J, Hagood J, Checa M, Ortiz-Quintero B, Negreros M, Herrera I, Ramos C, Pardo A, and Selman M (2012) Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 303:L295-L303.
25. Cohen SM (2009) Use of microRNA sponges to explore tissue-specific microRNA functions in vivo. Nat Methods 6:873-874.
26. Corvol H, Flamein F, Epaud R, Clement A, and Guillot L (2009) Lung alveolar epithelium and interstitial lung disease. Int J Biochem Cell Biol 41:1643-1651.
27. Coward WR, Watts K, Feghali-Bostwick CA, Knox A, and Pang L (2009) Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 29:4325-4339.
28. Coward WR, Feghali-Bostwick CA, Jenkins G, Knox AJ, and Pang L (2014) A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. FASEB J 28:3183-3196.
29. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, and Lü J (2011) miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45:287-294.
30. da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, and van der Nagel R, et al. (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12:1220-1227.
31. Dakhlallah D, Batte K, Wang Y, Cantemir-Stone CZ, Yan P, Nuovo G, Mikhail A, Hitchcock CL, Wright VP, and Nana-Sinkam SP, et al. (2013) Epigenetic regulation of miR-17∼92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 187:397-405.
32. Deaton AM and Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25:1010-1022.
33. Denby L, Ramdas V, Lu R, Conway BR, Grant JS, Dickinson B, Aurora AB, McClure JD, Kipgen D, and Delles C, et al. (2014) MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc Nephrol 25:65-80.
34. Diep QN, Benkirane K, Amiri F, Cohn JS, Endemann D, and Schiffrin EL (2004) PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J Mol Cell Cardiol 36:295-304.
35. Dong S, Ma W, Hao B, Hu F, Yan L, Yan X, Wang Y, Chen Z, and Wang Z (2014) microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol 7:565-574.
36. Du B, Ma LM, Huang MB, Zhou H, Huang HL, Shao P, Chen YQ, and Qu LH (2010) High glucose down-regulates miR-29a to increase collagen IV production in HK-2cells. FEBS Lett 584:811-816.
37. Duan WJ, Yu X, Huang XR, Yu JW, and Lan HY (2014) Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro. Am J Pathol 184:2275-2284.
38. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, and Barenbrug P, et al. (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of micro-RNAs in myocardial matrix remodeling. Circ Res 104:170-178.
39. Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, and Berger U, et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899.
40. Eng C, Herman JG, and Baylin SB (2000) A bird's eye view of global methylation. Nat Genet 24:101-102.
41. Esau CC (2008) Inhibition of microRNA with antisense oligonucleotides. Methods 44:55-60.
42. Espada J, Ballestar E, Fraga MF, Villar-Garea A, Juarranz A, Stockert JC, Robertson KD, Fuks F, and Esteller M (2004) Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J Biol Chem 279:37175-37184.
43. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861-874.
44. Fahy J, Jeltsch A, and Arimondo PB (2012) DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies. Expert Opin Ther Pat 22:1427-1442.
45. Fatica A and Bozzoni I (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15:7-21.
46. Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, and Callegari E, et al. (2012) In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 227:275-285.
47. Forte A, Della Corte A, De Feo M, Cerasuolo F, and Cipollaro M (2010) Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. Cardiovasc Res 88:395-405.
48. Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouyé S, Hazzan M, Pottier N, and Perrais M, et al. (2013) Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS ONE 8:e58014.
49. Guillemette B, Drogaris P, Lin HH, Armstrong H, Hiragami-Hamada K, Imhof A, Bonneil E, Thibault P, Verreault A, and Festenstein RJ (2011) H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet 7:e1001354.
50. Guo J and Sime PJ (2012) Yin yang 1 and histone methylation are associated with fibroblast differentiation. Am J Respir Crit Care Med 185:A3916.
51. Guo CJ, Pan Q, Jiang B, Chen GY, and Li DG (2009a) Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 14:1331-1340.
52. Guo CJ, Pan Q, Li DG, Sun H, and Liu BW (2009b) miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol 50:766-778.
53. Han H, Cortez CC, Yang X, Nichols PW, Jones PA, and Liang G (2011) DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum Mol Genet 20:4299-4310.
54. Han L and Zhao Z (2009) CpG islands or CpG clusters: how to identify functional GC-rich regions in a genome? BMC Bioinformatics 10:65.
55. He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, and Harris RC, et al. (2010) Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120:1056-1068.
56. He Y, Huang C, Sun X, Long XR, Lv XW, and Li J (2012) MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 24:1923-1930.
57. Huang J, Wang Y, Guo Y, and Sun S (2010a) Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52:60-70.
58. Huang SK, Fisher AS, Scruggs AM, White ES, Hogaboam CM, Richardson BC, and Peters-Golden M (2010b) Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am J Pathol 177:2245-2255.
59. Huang XZ, Wen D, Zhang M, Xie Q, Ma L, Guan Y, Ren Y, Chen J, and Hao CM (2014a) Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-b/Smad3 pathway. J Cell Biochem 115:996-1005.
60. Huang Y, Xu T, and Li J (2014b) Role of miR-208 in cardiac fibrosis: prevention or promotion? Arch Med Res 45:356.
61. Hubbard R, Venn A, Lewis S, and Britton J (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161:5-8.
62. Huleihel L, Ben-Yehudah A, Milosevic J, Yu G, Pandit K, Sakamoto K, Yousef H, LeJeune M, Coon TA, and Redinger CJ, et al. (2014) Let-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 306:L534-L542.
63. Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, and Kawada N (2012) Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair 5:12.
64. Imhof A and Wolffe AP (1998) Transcription: gene control by targeted histone acetylation. Curr Biol 8:R422-R424.
65. Inoue S and Oishi M (2005) Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11). Gene 348:123-134.
66. Io K, Nishino T, Obata Y, Kitamura M, Koji T, and Kohno S (2014) Saha suppresses peritoneal fibrosis in mice. Perit Dial Int DOI: 10.3747/pdi.2013.00089 [published ahead of print].
67. Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA, and Wheeler MD (2006) LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 290:G1318-G1328.
68. James TT, Aroor AR, Lim RW, and Shukla SD (2012) Histone H3 phosphorylation (Ser10, Ser28) and phosphoacetylation (K9S10) are differentially associated with gene expression in liver of rats treated in vivo with acute ethanol. J Pharmacol Exp Ther 340:237-247.
69. Ji J, Zhang J, Huang G, Qian J, Wang X, and Mei S (2009) Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583:759-766.
70. Ji W, Yang L, Yuan J, Yang L, Zhang M, Qi D, Duan X, Xuan A, Zhang W, and Lu J, et al. (2013) MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism. Carcinogenesis 34:446-453.
71. Jjingo D, Conley AB, Yi SV, Lunyak VV, and Jordan IK (2012) On the presence and role of human gene-body DNA methylation. Oncotarget 3:462-474.
72. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484-492.
73. Jüngel A, Distler JH, Gay S, and Distler O (2011) Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev Clin Immunol 7:475-480.
74. Karmodiya K, Krebs AR, Oulad-Abdelghani M, Kimura H, and Tora L (2012) H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genomics 13:424.
75. Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K, Utani A, Hirano A, and Yamashita S (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 132:1597-1604.
76. Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, and Beltrami AP, et al. (2011) Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 109:894-906.
77. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, and Natarajan R (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104:3432-3437.
78. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, and Todorov I, et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881-889.
79. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, and Yorioka N (2009) PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest 89:47-58.
80. Keller EF (2014) From gene action to reactive genomes. J Physiol 592:2423-2429.
81. Kim JS and Shukla SD (2005) Histone h3 modifications in rat hepatic stellate cells by ethanol. Alcohol Alcohol 40:367-372.
82. Kim YS, Kang WS, Kwon JS, Hong MH, Jeong HY, Jeong HC, Jeong MH, and Ahn Y (2014) Protective role of 5-azacytidine on myocardial infarction is associated with modulation of macrophage phenotype and inhibition of fibrosis. J Cell Mol Med 18:1018-1027.
83. Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Tsunematsu H, Li W, Miyagi T, Hosui A, and Tatsumi T, et al. (2011) Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest 121:3343-3356.
84. Komatsu Y, Waku T, Iwasaki N, Ono W, Yamaguchi C, and Yanagisawa J (2012) Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med Genomics 5:5.
85. Kozomara A and Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157.
86. Krämer M, Dees C, Huang J, Schlottmann I, Palumbo-Zerr K, Zerr P, Gelse K, Beyer C, Distler A, and Marquez VE, et al. (2013) Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann Rheum Dis 72:614-620.
87. Kriegel AJ, Fang Y, Liu Y, Tian Z, Mladinov D, Matus IR, Ding X, Greene AS, and Liang M (2010) MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res 38:8338-8347.
88. Kriegel AJ, Liu Y, Cohen B, Usa K, Liu Y, and Liang M (2012) MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis. Physiol Genomics 44:259-267.
89. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, and Stoffel M (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689.
90. Kulkarni AA, Thatcher TH, Olsen KC, Maggirwar SB, Phipps RP, and Sime PJ (2011) PPAR-g ligands repress TGFb-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PLoS ONE 6:e15909.
91. Kumar MS, Lu J, Mercer KL, Golub TR, and Jacks T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39:673-677.
92. Kwon KD, Choi MJ, Park JM, Song KM, Kwon MH, Batbold D, Yin GN, Kim WJ, Ryu JK, and Suh JK (2014) Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease. BJU Int DOI: 10.1111/bju.12812 [published ahead of print].
93. Lakner AM, Steuerwald NM, Walling TL, Ghosh S, Li T, McKillop IH, Russo MW, Bonkovsky HL, and Schrum LW (2012) Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56:300-310.
94. Lamouille S, Xu J, and Derynck R (2014) Molecular mechanisms of epithelialmesenchymal transition. Nat Rev Mol Cell Biol 15:178-196.
95. Lan HY (2011) Diverse roles of TGF-b/Smads in renal fibrosis and inflammation. Int J Biol Sci 7:1056-1067.
96. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, and Kalluri R (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047-1053.
97. Lee SB and Kalluri R (2010) Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl 78:S22-S26.
98. Lewis BP, Burge CB, and Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
99. Li P, Li J, Chen T, Wang H, Chu H, Chang J, Zang W, Wang Y, Ma Y, and Du Y, et al. (2014) Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis. Int J Mol Med 33:1554-1562.
100. Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia QM, Liu HM, He J, Yu HY, and Zhu L (2011) The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 278:1522-1532.
101. Lin SL, Kisseleva T, Brenner DA, and Duffield JS (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173:1617-1627.
102. Lin X, Sime PJ, Xu H, Williams MA, LaRussa L, Georas SN, and Guo J (2011) Yin yang 1 is a novel regulator of pulmonary fibrosis. Am J Respir Crit Care Med 183:1689-1697.
103. Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, and Dewaeles E, et al. (2013) miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet 9:e1003291.
104. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, and Abraham E (2010a) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207:1589-1597.
105. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW, Jr, Ferreri NR, Yeo NC, and Liang M (2010b) Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55:974-982.
106. Liu N, He S, Ma L, Ponnusamy M, Tang J, Tolbert E, Bayliss G, Zhao TC, Yan H, and Zhuang S (2013a) Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS ONE 8:e54001.
107. Liu Y, Wang Z, Wang J, Lam W, Kwong S, Li F, Friedman SL, Zhou S, Ren Q, and Xu Z, et al. (2013b) A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling. Liver Int 33:504-515.
108. Liu Y, Li X, Aryee MJ, Ekström TJ, Padyukov L, Klareskog L, Vandiver A, Moore AZ, Tanaka T, and Ferrucci L, et al. (2014) GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. Am J Hum Genet 94:485-495.
109. Lokk K, Modhukur V, Rajashekar B, Märtens K, Mägi R, Kolde R, Koltšina M, Nilsson TK, Vilo J, and Salumets A, et al. (2014) DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol 15:r54.
110. Lu D and Insel PA (2014) Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis. Am J Physiol Cell Physiol 306:C779-C788.
111. Lu Y, Xiao J, Lin H, Bai Y, Luo X, Wang Z, and Yang B (2009) A single antimicroRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple micro-RNAs offers an improved approach for microRNA interference. Nucleic Acids Res 37:e24.
112. Macfarlane LA and Murphy PR (2010) MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics 11:537-561.
113. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, and Mann DA (2010) MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138:705-714.
114. Martin C and Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6:838-849.
115. Masamune A, Nakano E, Hamada S, Takikawa T, Yoshida N, and Shimosegawa T (2014) Alteration of the microRNA expression profile during the activation of pancreatic stellate cells. Scand J Gastroenterol 49:323-331.
116. Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, and Distler JH, et al. (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62:1733-1743.
117. Mayol G, Martín-Subero JI, Ríos J, Queiros A, Kulis M, Suñol M, Esteller M, Gómez S, Garcia I, and de Torres C, et al. (2012) DNA hypomethylation affects cancerrelated biological functions and genes relevant in neuroblastoma pathogenesis. PLoS ONE 7:e48401.
118. Meng XM, Huang XR, Xiao J, Chung AC, Qin W, Chen HY, and Lan HY (2012) Disruption of Smad4 impairs TGF-b/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int 81:266-279.
119. Montgomery RL and van Rooij E (2011) Therapeutic advances in MicroRNA targeting. J Cardiovasc Pharmacol 57:1-7.
120. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, and Shimotohno K (2011) The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE 6:e16081.
121. Muth M, Theophile K, Hussein K, Jacobi C, Kreipe H, and Bock O (2010) Hypoxiainduced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression. J Transl Med 8:33.
122. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, and Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
123. Neri F, Krepelova A, Incarnato D, Maldotti M, Parlato C, Galvagni F, Matarese F, Stunnenberg HG, and Oliviero S (2013) Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 155:121-134.
124. Ning Q and Jiang X (2013) Angiotensin II upregulated the expression of microRNA-224 but not microRNA-21 in adult rat cardiac fibroblasts. Biomed Rep 1:776-780.
125. Oba S, Kumano S, Suzuki E, Nishimatsu H, Takahashi M, Takamori H, Kasuya M, Ogawa Y, Sato K, and Kimura K, et al. (2010) miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS ONE 5:e13614.
126. Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, and Yoshimura A (2006) Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 25:2520-2530.
127. Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, and Yuan Y, et al. (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation 126:840-850.
128. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, and Handley D, et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182:220-229.
129. Patel V and Noureddine L (2012) MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens 21:410-416.
130. Patil V, Ward RL, and Hesson LB (2014) The evidence for functional non-CpG methylation in mammalian cells. Epigenetics 9:823-828.
131. Perugorria MJ, Wilson CL, Zeybel M, Walsh M, Amin S, Robinson S, White SA, Burt AD, Oakley F, and Tsukamoto H, et al. (2012) Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology 56:1129-1139.
132. Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, and Beland FA (2010) Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 90:1437-1446.
133. Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, and Rios G, et al. (2009) Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS ONE 4:e6718.
134. Pottier N, Cauffiez C, Perrais M, Barbry P, and Mari B (2014) FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. Trends Pharmacol Sci 35:119-126.
135. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, and Lan HY (2011) TGF-βb/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22:1462-1474.
136. Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, and Kaminski N (2012) Global methylation patterns in idiopathic pulmonary fibrosis. PLoS ONE 7:e33770.
137. Rahman I, Marwick J, and Kirkham P (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and proinflammatory gene expression. Biochem Pharmacol 68:1255-1267.
138. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, Black JC, Hoffmann A, Carey M, and Smale ST (2009) A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-128.
139. Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, Fick L, Kanellopoulos J, Quesniaux VF, Marchand-Adam S, and Crestani B, et al. (2010) Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 182:774-783.
140. Rossetto D, Avvakumov N, and Côté J (2012) Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7:1098-1108.
141. Rossi M, Pitari MR, Amodio N, Di Martino MT, Conforti F, Leone E, Botta C, Paolino FM, Del Giudice T, and Iuliano E, et al. (2013) miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol 228:1506-1515.
142. Ryu JK, Kim WJ, Choi MJ, Park JM, Song KM, Kwon MH, Das ND, Kwon KD, Batbold D, and Yin GN, et al. (2013) Inhibition of histone deacetylase 2 mitigates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque. Asian J Androl 15:640-645.
143. Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, and Hagood JS (2008) Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 39:610-618.
144. Sanders YY, Hagood JS, Liu H, Zhang W, Ambalavanan N, and Thannickal VJ (2014) Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. Eur Respir J 43:1448-1458.
145. Sayed D, Hong C, Chen IY, Lypowy J, and Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424.
146. Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, Mba MU, Massey HD, King AL, and Gehr T, et al. (2011) MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 11:2110-2122.
147. Sela M, Kloog Y, and Rechavi O (2014) Non-coding RNAs as the bridge between epigenetic mechanisms, lineages and domains of life. J Physiol 592:2369-2373.
148. Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, Wang N, Li X, Feng T, and Hong Y, et al. (2009) Downregulation of miR-133 and miR-590 contributes to nicotineinducedatrial remodelling in canines. Cardiovasc Res 83:465-472.
149. Shenderov BA and Midtvedt T (2014) Epigenomic programing: a future way to health? Microb Ecol Health Dis 25:24145-24152.
150. Simic P, Williams EO, Bell EL, Gong JJ, Bonkowski M, and Guarente L (2013) SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. Cell Reports 3:1175-1186.
151. Sohn SY, Bae WJ, Kim JJ, Yeom KH, Kim VN, and Cho Y (2007) Crystal structure of human DGCR8 core. Nat Struct Mol Biol 14:847-853.
152. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, and Szyf M (2011) Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 71:5891-5903.
153. Stefanska B, Suderman M, Machnes Z, Bhattacharyya B, Hallett M, and Szyf M (2013) Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. Carcinogenesis 34: 2738-2749.
154. Stramer BM, Mori R, and Martin P (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127: 1009-1017.
155. Strieter RM, Keeley EC, Hughes MA, Burdick MD, and Mehrad B (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 86:1111-1118.
156. Subramaniam D, Thombre R, Dhar A, and Anant S (2014) DNA methyltransferases: a novel target for prevention and therapy. Front Oncol 4:80.
157. Sun G, Reddy MA, Yuan H, Lanting L, Kato M, and Natarajan R (2010) Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol 21: 2069-2080.
158. Sun X, He Y, Huang C, Ma TT, and Li J (2013) The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases. Cell Signal 25:1870-1876.
159. Takai D and Jones PA (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99:3740-3745.
160. Takenaka K, Gemma A, Yoshimura A, Hosoya Y, Nara M, Hosomi Y, Okano T, Kunugi S, Koizumi K, and Fukuda Y, et al. (2009) Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis. Mol Med Rep 2:73-80.
161. Tamaru H and Selker EU (2001) A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414:277-283.
162. Tao H, Huang C, Yang JJ, Ma TT, Bian EB, Zhang L, Lv XW, Jin Y, and Li J (2011) MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology 290:327-333.
163. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, and Frantz S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984.
164. Turner NA and Porter KE (2013) Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 6:5.
165. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, and Heymans S, et al. (2011) MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in agerelated heart failure. Aging Cell 10:769-779.
166. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, and Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-579.
167. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, and Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032.
168. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, and Zern MA (2010) Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298:G101-G106.
169. Wallace MC and Friedman SL (2014) Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development. Gene Expr 16:77-84.
170. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, and Cooper ME, et al. (2010) E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 59:1794-1802.
171. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, and Cooper ME, et al. (2011) miR-200a Prevents renal fibrogenesis through repression of TGF-b2 expression. Diabetes 60: 280-287.
172. Wang BW, Wu GJ, Cheng WP, and Shyu KG (2014) MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart. PLoS ONE 9:e84188.
173. Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J, Xu X, Hu S, and Zheng Z (2012) MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 16:2150-2160.
174. Wang L, Wang WL, Zhang Y, Guo SP, Zhang J, and Li QL (2007) Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res 37:389-396.
175. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X, and Quigg RJ (2008a) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22:4126-4135.
176. Wang Y, Fan PS, and Kahaleh B (2006) Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 54:2271-2279.
177. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, and Zhang MQ, et al. (2008b) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40:897-903.
178. Watson CJ, Collier P, Tea I, Neary R, Watson JA, Robinson C, Phelan D, Ledwidge MT, McDonald KM, and McCann A, et al. (2014) Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Hum Mol Genet 23:2176-2188.
179. Willis BC, duBois RM, and Borok Z (2006) Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 3:377-382.
180. Wong NC, Wong LH, Quach JM, Canham P, Craig JM, Song JZ, Clark SJ, and Choo KH (2006) Permissive transcriptional activity at the centromere through pockets of DNA hypomethylation. PLoS Genet 2:e17.
181. Wu CH, Tang SC, Wang PH, Lee H, and Ko JL (2012) Nickel-induced epithelialmesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem 287:25292-25302.
182. Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ, and Lan HY (2012) miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20:1251-1260.
183. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, and Yang J (2012) The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 302:F369-F379.
184. Yamada M, Kubo H, Ota C, Takahashi T, Tando Y, Suzuki T, Fujino N, Makiguchi T, Takagi K, and Suzuki T, et al. (2013) The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells. Respir Res 14:95.
185. Yang L, Chan CC, Kwon OS, Liu S, McGhee J, Stimpson SA, Chen LZ, Harrington WW, Symonds WT, and Rockey DC (2006) Regulation of peroxisome proliferatoractivated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 291:G902-G911.
186. Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, Thannickal VJ, Abraham E, and Liu G (2012) Participation of miR-200 in pulmonary fibrosis. Am J Pathol 180:484-493.
187. Yao Q, Cao S, Li C, Mengesha A, Kong B, and Wei M (2011) Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction. Int J Cancer 128:1783-1792.
188. Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H, and Yoshimura A (2004) SOCS1 is a suppressor of liver fibrosis and hepatitisinduced carcinogenesis. J Exp Med 199:1701-1707.
189. Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Wu CW, Tong L, Zhao J, and Poon TC, et al. (2010) Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro. Int J Biochem Cell Biol 42:948-957.
190. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, and Kalluri R (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968.
191. Zerr P, Palumbo-Zerr K, Huang J, Tomcik M, Sumova B, Distler O, Schett G, and Distler JH (2014) Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis. Ann Rheum Dis DOI: 10.1136/annrheumdis-2014-205740 [published ahead of print].
192. Zhang H, Liu X, Chen S, Wu J, Ye X, Xu L, Chen H, Zhang D, Tan R, and Wang Y (2010) Tectorigenin inhibits the in vitro proliferation and enhances miR-338∗ expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis. J Ethnopharmacol 131:165-173.
193. Zhang QJ, Chen HZ, Wang L, Liu DP, Hill JA, and Liu ZP (2011) The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest 121:2447-2456.
194. Zhang X, Liu H, Hock T, Thannickal VJ, and Sanders YY (2013a) Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts. Int J Mol Sci 14: 19605-19617.
195. Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM, and Lan HY (2014) miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGFβ/Smad3 signaling. Mol Ther 22:974-985.
196. Zhang Y and Reinberg D (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15:2343-2360.
197. Zhang Z, Zha Y, Hu W, Huang Z, Gao Z, Zang Y, Chen J, Dong L, and Zhang J (2013b) The autoregulatory feedback loop of microRNA-21/programmed cell death protein4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem 288:37082-37093.
198. Zhao Q, Fan YC, Zhao J, Gao S, Zhao ZH, and Wang K (2013a) DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B. J Viral Hepat 20: 430-437.
199. Zhao Q, Qin CY, Zhao ZH, Fan YC, and Wang K (2013b) Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis. Tohoku J Exp Med 229: 35-43.
200. Zheng L, Chen X, Guo J, Sun H, Liu L, Shih DQ, and Zhang X (2012) Differential expression of PTEN in hepatic tissue and hepatic stellate cells during rat liver fibrosis and its reversal. Int J Mol Med 30:1424-1430.
201. Zhong X, Chung AC, Chen HY, Meng XM, and Lan HY (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668-1681.
202. Zhou L, Wang L, Lu L, Jiang P, Sun H, and Wang H (2012) Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS ONE 7:e33766.
203. Zhu H, Luo H, and Zuo X (2013) MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma. Exp Mol Med 45:e41.